POTENTIA PHARMACEUTICALS INC has a total of 37 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ALBA THERAPEUTICS CORP, ENDOCYTE INC and RETINAL SOLUTIONS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Japan | 5 | |
#4 | China | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Australia | 2 | |
#7 | Brazil | 2 | |
#8 | Canada | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 2 | |
#11 | Israel | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Implantable devices | |
#6 | Object sterilising | |
#7 | Measuring microorganism processes | |
#8 | Microorganisms | |
#9 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Deschatelets Pascal | 31 |
#2 | Francois Cedric | 26 |
#3 | Olson Paul | 24 |
#4 | Paul Olson | 9 |
#5 | Cedric Francois | 8 |
#6 | Pascal Deschatelets | 4 |
#7 | Deschastelets Pascal | 1 |
#8 | Cedric François | 1 |
Publication | Filing date | Title |
---|---|---|
MX2010003630A | Sustained delivery of compstatin analogs from gels. | |
US2008075755A1 | Viral complement control proteins for eye disorders | |
EP2662089A2 | Compstatin and analogs thereof for eye disorders | |
US2006142191A1 | Viral complement control proteins for eye disorders |